Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian E Sattui

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
Rheumatic Diseases Clinics of North America|April 8, 2014
Comorbidities in patients with crystal diseases and hyperuricemiaSebastian E Sattui, Jasvinder A Singh, Angelo L Gaffo
Arthritis Care & Research|August 29, 2023
Incidence of Pneumocystis Jiroveci Pneumonia in Patients With ANCA-Associated Vasculitis Initiating Therapy With Rituximab or CyclophosphamideElizabeth Nettleton, Sebastian E Sattui, Zachary Wallace, et al.
Clinical Therapeutics|October 26, 2013
Systematic review of tumor necrosis factor inhibitor discontinuation studies in rheumatoid arthritisIris Navarro-Millán, Sebastian E Sattui, Jeffrey R Curtis
Rheumatology (Oxford, England)|October 29, 2020
Comment on: Handgrip strength is a comorbidity marker in systemic necrotizing vasculitides and predicts the risk of fracture and serious adverse eventsSebastian E Sattui, Sarah B Lieber, Katherine D Wysham
Current Opinion in Rheumatology|December 6, 2024
Epidemiology of systemic vasculitisMehmet Hocaoglu, Brian Jaros, Anisha B Dua, et al.
Current Rheumatology Reports|April 26, 2024
Current perspective on infections and mitigation strategies in primary systemic vasculitisManuel Carpio Tumba, Raisa Lomanto Silva, Ana B Arevalo, et al.
The Lancet. Rheumatology|November 14, 2024
Frailty and rheumatic diseases: evidence to date and lessons learnedSarah B Lieber, Katherine D Wysham, Sebastian E Sattui, et al.
The Lancet. Rheumatology|November 14, 2024
Cognitive impairment in individuals with rheumatic diseases: the role of systemic inflammation, immunomodulatory medications, and comorbiditiesElena Myasoedova, Sebastian E Sattui, Jiha Lee, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 23, 2021
ANCA-Associated Vasculitis in Latin America: A Systematic Literature Review: About Their Epidemiology and Their Clinical FeaturesVictor R Pimentel-Quiroz, Sebastian E Sattui, Manuel F Ugarte-Gil, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|April 26, 2022
Response to Letter to the Editor: Comment on the Review Article: "ANCA-Associated Vasculitis in Latin America. A systematic Literature Review: About Their Epidemiology and Their Clinical Features" by Victor R. Pimentel-Quiroz, et al. (J Clin Rheumatol 2022;28:44-51)Victor R Pimentel-Quiroz, Sebastian E Sattui, Manuel F Ugarte-Gil, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Rheumatic Diseases Clinics of North America|April 8, 2014
Comorbidities in patients with crystal diseases and hyperuricemiaSebastian E Sattui, Jasvinder A Singh, Angelo L Gaffo
Arthritis Care & Research|August 29, 2023
Incidence of Pneumocystis Jiroveci Pneumonia in Patients With ANCA-Associated Vasculitis Initiating Therapy With Rituximab or CyclophosphamideElizabeth Nettleton, Sebastian E Sattui, Zachary Wallace, et al.
Clinical Therapeutics|October 26, 2013
Systematic review of tumor necrosis factor inhibitor discontinuation studies in rheumatoid arthritisIris Navarro-Millán, Sebastian E Sattui, Jeffrey R Curtis
Rheumatology (Oxford, England)|October 29, 2020
Comment on: Handgrip strength is a comorbidity marker in systemic necrotizing vasculitides and predicts the risk of fracture and serious adverse eventsSebastian E Sattui, Sarah B Lieber, Katherine D Wysham
Current Opinion in Rheumatology|December 6, 2024
Epidemiology of systemic vasculitisMehmet Hocaoglu, Brian Jaros, Anisha B Dua, et al.
Current Rheumatology Reports|April 26, 2024
Current perspective on infections and mitigation strategies in primary systemic vasculitisManuel Carpio Tumba, Raisa Lomanto Silva, Ana B Arevalo, et al.
The Lancet. Rheumatology|November 14, 2024
Frailty and rheumatic diseases: evidence to date and lessons learnedSarah B Lieber, Katherine D Wysham, Sebastian E Sattui, et al.
The Lancet. Rheumatology|November 14, 2024
Cognitive impairment in individuals with rheumatic diseases: the role of systemic inflammation, immunomodulatory medications, and comorbiditiesElena Myasoedova, Sebastian E Sattui, Jiha Lee, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 23, 2021
ANCA-Associated Vasculitis in Latin America: A Systematic Literature Review: About Their Epidemiology and Their Clinical FeaturesVictor R Pimentel-Quiroz, Sebastian E Sattui, Manuel F Ugarte-Gil, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|April 26, 2022
Response to Letter to the Editor: Comment on the Review Article: "ANCA-Associated Vasculitis in Latin America. A systematic Literature Review: About Their Epidemiology and Their Clinical Features" by Victor R. Pimentel-Quiroz, et al. (J Clin Rheumatol 2022;28:44-51)Victor R Pimentel-Quiroz, Sebastian E Sattui, Manuel F Ugarte-Gil, et al.
Pageof 8